From: A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
No. of patients
The 3-year PFS (%)
P-value
The 3-year OS (%)
All patients
24
87.5
-
91.5
Stage
IIa2
3
3/3
IIb
18
88.9
IIIb
2/3
0.360
0.710